Hamilton Medical Logo Hamilton Logo
Back

Our NIV mask portfolio - Offering comfort to your patients

News

Date of first publication: 07.10.2022

Hamilton Medical has joined forces with Pulmodyne to offer a comprehensive range of interfaces for your patients.
Our NIV mask portfolio - Offering comfort to your patients

Alternate mask type during treatment

Prolonged wearing of NIV masks may lead to the development of pressure ulcers (Grieco DL, Maggiore SM, Roca O, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851-866. doi:10.1007/s00134-021-06459-21​). One way to guard against this is to alternate the mask type during treatment - that’s why we offer a wide range of masks in different sizes and configurations. Our product portfolio includes masks for both pediatrics and adults in different configurations and sizes, either vented or non-vented and with or without an anti-asphyxia valve. They are all designed to increase patient comfort and compliance in respiratory distress scenarios.

  • Their optimal fit soothes the pressure points.
  • The double-lip design of the cushion provides an efficient seal.
  • The forehead cushion keeps the mask in position and does not compromise the wearing comfort.

You can choose from nasal, full face, or total perimeter configurations to ensure the most suitable fit for each individual patient. If you are wondering about the differences between the various configurations, here is a quick overview:

Nasal masks (BiTrac NIV)

The nasal masks (Only available in the USA​) complement the full face masks. Their position on the nose gives patients the freedom to eat and talk, thereby improving their quality of life. They also reduce the amount of skin at risk of developing pressure ulcers. However, the efficacy of these masks depends on the patient keeping their mouth closed.

Patient in bed wearing nasal mask
Patient in bed wearing nasal mask

Full face masks (BiTrac NIV)

The full face masks are the standard for treatment with NIV. They are intended for patients with high respiratory demands or spontaneously breathing patients needing noninvasive ventilation (NIV) for respiratory support. The shape of the mask allows the patient to breathe through their mouth, so CO2 elimination is smoother as there is minimal nasal resistance.

Patient in bed wearing full face mask
Patient in bed wearing full face mask

Total perimeter masks (BiTrac MaxShield)

The total perimeter masks avoid direct pressure on the nose, instead dispersing it over a larger surface area. They can also reduce the feeling of claustrophobia for the patient. By sealing around the perimeter of the face, the masks provide a great solution in the case of nasal bridge challenges or other facial deformations and abnormalities.

Patient in bed wearing total perimeter mask
Patient in bed wearing total perimeter mask

For detailed ordering information, con­tact your local Hamilton Medical representative or visit our Hamilton Medical e-catalog.

Follow the link below to explore our guide to the full range of masks.

 

NIV masks

Footnotes

  • A. Only available in the US

References

  1. 1. Grieco DL, Maggiore SM, Roca O, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851-866. doi:10.1007/s00134-021-06459-2

Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.

Grieco DL, Maggiore SM, Roca O, et al. Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021;47(8):851-866. doi:10.1007/s00134-021-06459-2

The role of non-invasive respiratory support (high-flow nasal oxygen and noninvasive ventilation) in the management of acute hypoxemic respiratory failure and acute respiratory distress syndrome is debated. The oxygenation improvement coupled with lung and diaphragm protection produced by non-invasive support may help to avoid endotracheal intubation, which prevents the complications of sedation and invasive mechanical ventilation. However, spontaneous breathing in patients with lung injury carries the risk that vigorous inspiratory effort, combined or not with mechanical increases in inspiratory airway pressure, produces high transpulmonary pressure swings and local lung overstretch. This ultimately results in additional lung damage (patient self-inflicted lung injury), so that patients intubated after a trial of noninvasive support are burdened by increased mortality. Reducing inspiratory effort by high-flow nasal oxygen or delivery of sustained positive end-expiratory pressure through the helmet interface may reduce these risks. In this physiology-to-bedside review, we provide an updated overview about the role of noninvasive respiratory support strategies as early treatment of hypoxemic respiratory failure in the intensive care unit. Noninvasive strategies appear safe and effective in mild-to-moderate hypoxemia (PaO2/FiO2 > 150 mmHg), while they can yield delayed intubation with increased mortality in a significant proportion of moderate-to-severe (PaO2/FiO2 ≤ 150 mmHg) cases. High-flow nasal oxygen and helmet noninvasive ventilation represent the most promising techniques for first-line treatment of severe patients. However, no conclusive evidence allows to recommend a single approach over the others in case of moderate-to-severe hypoxemia. During any treatment, strict physiological monitoring remains of paramount importance to promptly detect the need for endotracheal intubation and not delay protective ventilation.